Key Companies in the AAV Vector Manufacturing Market: Thermo Fisher Scientific, Catalent Gene Therapy, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, WuXi Advanced Therapies, ...
Five poster presentations will highlight exciting progress in AskBio’s adeno-associated virus (AAV) manufacturing ...
A single AAV injection carrying the leptin gene normalised fasting insulin and fully reversed hepatic triglyceride ...
Gene therapy adeno-associated viruses (AAVs)—viruses that can be engineered to deliver DNA to target cells—are unlikely to cause cancer-triggering insertions in humans or monkeys and may contribute to ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced ...
Together with the existing Vericheck ddPCR Empty-Full Capsid Kits for serotypes AAV5 and AAV9, the addition of the new kits for serotypes AAV2 and AAV8 extends the range’s suitability to approximately ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, today announced that Roche (SIX: RO, ...
SAN FRANCISCO—Kicking off J.P. Morgan week, Dyno Therapeutics announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological ...
A mouse study found that intrastromal adeno-associated virus delivery labeled corneal-projecting trigeminal neurons and ...